THEY WANT YOU DEAD: Johns Hopkins Hospital Owns The Mebendazole Polymorph Patent for The TREATMENT AND PREVENTION OF TUMORS
⚠️ THE LIFESAVING FLASH SALE HAS BEEN EXTENDED ⚠️
This is an important update to yesterday’s article that further establishes that the Medical-Industrial Complex, which is the “health” node asset of the 4th Branch of Government Intelligence-Industrial Complex…
…have been for many decades now in possession of the cure for cancer.
At the height of the PSYOP-19 scamdemic all of the NWO globopedo eugenicists knew full well that the Modified mRNA slow kill bioweapon “vaccines” would induce a turbo cancer epidemic given that spike proteins suppress the “guardian of the genome” p53 protein, which in turn prevents cancer, and that the extremely carcinogenic gene altering SV40 promotor sequences were deliberately added to these depopulation injections.
They also knew that Ivermectin and benzimidazole-class anthelmintic drugs would cure their inevitable forthcoming turbo cancer outbreak.
Which is precisely why Johns Hopkins, yes, the very same Johns Hopkins that hosted the high-level pandemic exercise on October 18, 2019 known as EVENT 201 alongside their partners-in-crime the WEF, Bill and Melinda Gates Foundation and the CIA, finally locked up their grift patent for Mebendazole just two years later to perfectly coincide with the commencement of exploding VAIDS-induced cancer cases; to wit:
The patent was actually filed on February 8th, 2016, and it is important to appreciate that Johns Hopkins and all of the other PSYOP-19 players were working on this gain-of-function plandemic since the 1990s, or why Operation Warp Speed was anything but warp speed; in other words, they knew that they were going to unleash a turbo cancer scourge at some point in the future, which is why they started work on locking up patents for inexpensive and easily accessible cancer treatments.
Since Ivermectin could not be patented for cancer, nor could Hydroxychloroquine, nor Fenbendazole, the BigPharma criminals came up with the idea of chemically altering the latter in order to be awarded a bogus Mebendazole patent; to wit:
SUMMARY OF THE INVENTION
According to one aspect of the invention a pharmaceutical formulation of mebendazole is provided. At least 90% of the mebendazole in the formulation is polymorph C, and the formulation is granulated
According to another aspect of the invention a pharmaceutical formulation of mebendazole is provided that comprises polymorph C and an inhibitor of P-glycoprotein.
According to another aspect of the invention a pharmaceutical formulation that comprises mebendazole and a non-steroidal anti-inflammatory drug (NSAID) is provided.
Another aspect of the invention is a method of administering a pharmaceutical mebendazole formulation. The pharmaceutical mebendazole formulation can be a granulated formulation in which at least 90% of the mebendazole in the formulation 1s polymorph C, or it can be a combination formulation of polymorph C and an inhibitor of P-glyco-protein, or it can be a formulation of mebendazole comprising polymorph C and an NSAID. According to the method, the formulation is applied to a food prior to ingestion of the food
According to still another aspect of the invention a method is provided to monitor anti-cancer potency of a mebendazole pharmaceutical formulation. A pharmaceutical formulation comprising mebendazole is assayed, and the amount of polymorph C and amount of polymorph A are determined
Another aspect of the invention is a method of treating a tumor or reducing the risk of developing a tumor in a human.
A pharmaceutical formulation of mebendazole, whether a granulated formulation in which at least 90% of the mebendazole is polymorph C, or a combination formulation of polymorph C and an inhibitor of P-glycoprotein, or a combination formulation of polymorph C and an NSAID, is administered or dispensed to a human for oral ingestion. The human either has a tumor or is at elevated risk of developing a tumor.
An additional aspect of the invention is a kit for treating tumors or reducing the risk of developing tumors). The kit comprises (a) mebendazole (optionally comprising poly-morph C) and (b) an inhibitor of P-glycoprotein or an NSAID.
Yet another aspect of the invention is a method of treating a tumor in a human or reducing the risk of developing a tumor. Mebendazole (optionally comprising polymorph C) and either an inhibitor of P-glycoprotein or an NSAID are administered or dispensed to the human for oral ingestion.
These and other embodiments which will be apparent to those of skill in the art upon reading the specification provide the art with tools for combatting highly refractory cancers.
The patent in its entirety:
They were even discussing prophylaxis in this patent, which further proves that they always knew the true nature of cancer is akin to parasitic disease.
So, why exactly then is this patent yet another total scam?
Because Fenbendazole is superior to Mebendazole, thus there was never any reason to ever file for the patent.
Fenbendazole and Mebendazole both have similar core structures - a benzene ring fused to an imidazole ring - but they differ in their side chains such that Fenbendazole features a thioether group and a phenyl ring attached to the benzimidazole core, whereas Mebendazole has a carbamate group (a carbon atom bonded to an oxygen and nitrogen) in place of Fenbendazole's thioether.
In plain English, what that means is that Fenbendazole has higher oral bioavailability (30–50%) compared to Mebendazole (5–10%), and Fenbendazole is far more bioavailable by undergoing extensive hepatic metabolism, forming active metabolites like oxfendazole, while mebendazole is largely excreted unchanged.
Also, Fenbendazole has a higher affinity for tubulin, which means it shows higher affinity for nematode β-tubulin, potentially enhancing its safety profile.
Fenbendazole is far superior to Mebendazole at disrupting cancer cell microtubules, stopping cancer cell division, interfering with cancer metabolism and triggering cancer cell death.
(It is very important to note here that as per research studies, Fenbendazole becomes far more bioavailable when combined with multivitamins and nutraceuticals, and administered with fatty meals.)
But Johns Hopkins and their BigPharma coconspirators had no way to patent Fenbendazole, so they cooked up an inferior compound which could never cure cancer as efficiently, effectively and rapidly as the original compound, and are yet again using the criminal FDA to enforce their fraudulent “ approved for human use” con.
The following treatment approach that the Intelligence-Industrial Complex and their various partners-in-crime like Johns Hopkins are desperate for you to never know about represents not only the ‘holy grail’ cancer cure in plain sight, but may also treat Alzheimer’s, mood disorders, Parkinson’s, Lyme Disease, myocarditis, Hashimoto’s Disease, leukemia, Lupus, skin conditions, and various other “incurable” ailments, as well as the common cold and seasonal flu:
The Ultimate Disease Cure & Prophylaxis Protocol
Tocotrienol and Tocopherol forms (all 8) of Vitamin E (400-800mg per day, 7 days a week). A product called Gamma E by Life Extension or Perfect E are both great.
Bio-Available Curcumin (600mg per day, 2 pills per day 7 days a week). A product called Theracurmin HP by Integrative Therapeutics is bioavailable.
Vitamin D (62.5 mcg [2500 IU] seven days a week).
CBD oil (1-2 droppers full [equal to 167 to 334 mg per day] under the tongue, 7 days a week) CBD-X: The most potent full spectrum organic CBD oil, with 5,000 milligrams of activated cannabinoids and hemp compounds CBD, CBN & CBG per serving.
Fenbendazole (300mg, 7 days a week) or in the case of severe turbo cancers up to 1 gram — for prophylaxis one 150mg tablet once or twice per week
Ivermectin (24mg, 7 days a week) or in the case of severe turbo cancers up to 1mg/kg/day — for prophylaxis one 12mg tablet once or twice per week
Hydroxychloroquine (10mg/kg/day 7 days a week) - for prophylaxis one 200mg tablet once or twice per week
Doxycycline (100mg, 7 days a week for 30-60 days)
VIR-X immune support which also greatly increases the bioavailability of both Fenbendazole and Hydroxychloroquine (2 capsules per day) — for prophylaxis 2 capsules per day
Removing sugars and carbohydrates (cancer food) from your diet and replacing table sugar with a zero glycemic index, zero calorie, keto friendly rare sugar like FLAV-X
Do NOT comply.
⚠️ THE 25% OFF LIFESAVING FLASH SALE has been extended, so please use code IVM25 to receive 25% off on the newest product Hydroxychloroquine, as well as ALL of the amazing lifesaving products that you have been purchasing for many years now like the Nobel Prize winning miracle compound Ivermectin, the no less miraculous Fenbendazole, Doxycycline, the full spectrum organic CBD oil containing 5,000 milligrams of activated cannabinoids and hemp compounds CBD, CBN & CBG, the powerful immune support nutraceutical and spike support formula VIR-X, and the sugar craving reducing, blood sugar balancing and even anti-cancer allulose sugar substitute FLAV-X! ⚠️
THE MASSIVE 25% OFF LIFESAVING FLASH SALE ends Wednesday, March 11th (midnight eastern time), 2026.
Upon adding products to your cart, please go to the cart icon at the top right corner of your browser page and click it, then choose the VIEW CART option whereby you will be redirected to a page where you can enter the code IVM25 in the Use Coupon Code field.
Only the RESOLVX HEALTH website offers all of the authentic products that this Substack promotes.
Please contact the company directly with any product questions: info@resolvx.health
PS the majority of oncologists and Johns Hopkins are still peddling their insanely lucrative chemotherapy instead of treatments that actually work....
People are rightfully outraged by cover up of antiparasitics as cures for most cancers. I think the CIA is innocent of any wrongdoing because it’s reasonable that a low level analyst received the intelligence that the Russians could cure cancer with antiparasitics since the 1930s but simply did not believe it. The memo was filed and forgotten until the FOIA dump. That memo only gained meaning when my book on Cancer is a Parasite came out last week exposing and definitively proving a later coverup involving a fenbendazole derivative. It’s a fascinating read. https://www.dailymail.co.uk/sciencetech/article-15629211/cia-cancer-cure-document-declassified.html?ito=native_share_article-nativemenubutton